Respiratory

COVID-19 infection raises risks of asthma, rhinitis, and sinusitis, while vaccination reduces respiratory type-2 inflammatory disease incidence.

Respiratory viruses such as influenza and SARS-CoV-2 can awaken dormant breast cancer cells, driving metastasis and raising mortality risk in cancer survivors, new research finds.

A registry-based analysis using Bayesian modelling has mapped the pathways linking biomarkers, lung function, and comorbidities to severe asthma exacerbation risk.

A UK registry study shows asthma biologics improve outcomes across BMI groups, but obese patients remain more likely to have uncontrolled disease.

A large pooled analysis shows that kidney problems are common in PAH and CTEPH, worsen survival, and see only minor improvement with current pulmonary hypertension therapies.

Meta-analysis confirms low income is linked to increased asthma exacerbations, especially in children, highlighting income inequality as a key risk factor.

A global trial finds a shorter all-oral regimen for pre-XDR tuberculosis fails to match the efficacy of standard care, with poorer results in those with extensive disease.

A new Europe-wide analysis reveals that RSV hospitalisations in older adults are far more common than previously reported, highlighting the importance of updated data in vaccine policy planning.